학술논문

Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)
Document Type
Article
Source
In Blood 8 February 2024 143(6):496-506
Subject
Clinical Trials and Observations
Gene Therapy
Free Research Articles
Lymphoid Neoplasia
Language
ISSN
0006-4971